Formatech, Inc.
200 Bulfinch Drive
Andover
Massachusetts
01810
United States
Tel: 978-725-9077
Fax: 978-725-9078
Website: http://www.formatech.com/
Email: info@formatech.com
About Formatech, Inc.
Formatech, Inc. is a contract development services company and aseptic clinical supply manufacturer. Formatech's experience encompasses biotherapeutics and synthetically derived pharmaceuticals in all stages of the product development process. Formatech, Inc. serves biotechnology and pharmaceutical companies ranging in size from virtual to fully integrated. The company philosophy dictates that individual problems demand individual solutions. "We formulate solutions‚" embodies Formatech's proven ability to formulate need-specific solutions to complex product development, characterization and manufacturing issues.Key Services
- Pre-formulation development
- Formulation development
- Dosage form development
- Cell culture (E. coli and CHO)
- Biopharmaceutical purification/process development
- Stability FingerPrintingTM
- Lyophilization development
- Aseptic filling of liquid clinical batches
- Production of lyophilized clinical batches
- Fully validated Class 100 environment
- Technology transfer of final product manufacture
Contact
Last Updated 8-28--01
17 articles about Formatech, Inc.
-
Formatech, Inc. to Donate Services to Formulate and Fill Femta Pharmaceuticals’ FM101 Monoclonal Antibody under Its "Fillanthropy(TM) Program"
7/30/2010
-
Formatech, Inc. Donates Manufacturing Services to RegeneRx Biopharmaceuticals, Inc. to Produce Experimental Drug for the Treatment of Multiple Sclerosis
4/30/2010
-
Formatech, Inc. Donates Services to Formulate and Fill TRACON Pharmaceuticals, Inc.'s TRC102 Compound under Its "Fillanthropy(TM) Program"
3/22/2010
-
Cellceutix Signs Agreement for Kevetrin(TM) Formulation With Formatech, Inc.
3/22/2010
-
USPTO Grants Formatech Novel Drug Formulation Patent
2/12/2010
-
Formatech, Inc. Donates over $300K in Manufacturing Services Through "Fillanthropy Program"
1/29/2010
-
Formatech, Inc. Donates over $300K in Manufactuing Services Through "Fillanthropy Program"
1/28/2010
-
Formatech, Inc.'s "Fillanthropy Program" Donates Services to Formulate and Fill ViroMed's VM206 Vaccine Targeting Breast Cancer
1/5/2010
-
Formatech, Inc. Release: The New Face of Formatech.com
11/20/2009
-
Formatech, Inc. to Donate Services to Manufacture KAI Pharmaceuticals, Inc.'s Clinical Candidate Under Its "Fillanthropy(TM) Program"
11/18/2009
-
Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs Inc. HIV/AIDS Vaccine under Its "Fillanthropy(TM) Program"
10/15/2009
-
Formatech, Inc. Sponsors Massachusetts Biotechnology Education Foundation
8/14/2009
-
Formatech, Inc. Donates Manufacturing Services with New "Fillanthropy(TM) Program"
8/6/2009
-
ImmunoCellular Therapeutics, Ltd Signs Manufacturing Agreement with Formatech, Inc. for Clinical Trial of ICT-121 Immunotherapy
6/24/2009
-
ImmunoCellular Therapeutics, Ltd Signs Agreement with Formatech, Inc. for Development of Optimal Cancer Stem Cell Vaccine Formulation
3/10/2009
-
Formatech, Inc. Announces the Addition and Validation of a Second Lyophilizer to Meet an Increasing Demand for the Production of Freeze-Dried Sterile Injectable Products
3/6/2009
-
USPTO Grants Formatech, Inc. Novel Drug Formulation Patent
9/16/2008